The World Health Organization (WHO) has advised that two cough syrups manufactured by the Noida-based Marion Biotech should not be used on children in Uzbekistan.
In a medical product alert on Wednesday, the WHO said the “substandard medical products”, manufactured by Marion Biotech, “are products that fail to meet quality standards or specifications and are therefore out of specification.” “This WHO Medical Product Alert refers to two substandard (contaminated) products, identified in Uzbekistan and reported to WHO on 22 December 2022. Substandard medical products are products that fail to meet quality standards or specifications and are therefore out of specification,” the WHO said in an alert released on its website.
“The two products are AMBRONOL syrup and DOK-1 Max syrup. The stated manufacturer of both products is MARION BIOTECH PVT. LTD, (Uttar Pradesh, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert added.
Pharma company based in Noida Marion Biotech has come under fire after reports of children dying after consuming cough syrup from Uzbekistan surfaced.
According to WHO, laboratory analysis of cough syrup samples performed by national quality control laboratories of the Republic of Uzbekistan’s Ministry of Health revealed that both products contained unacceptable amounts of diethylene glycol and/or ethylene glycol as contaminants.
“Both of these products may have marketing authorizations in other countries in the region. They may also have been distributed, through informal markets, to other countries or regions,” the WHO alert added.
The UN health agency added that “the substandard products referenced in this Alert are unsafe and their use, especially in children, may result in serious injury or death.”
On December 22, Uzbekistan alleged that 18 children had died after consuming medicines manufactured by Marion Biotech company. On Tuesday, Uttar Pradesh Food Safety and Drug Administration department suspended the production licence of Marion Biotech company linked to Uzbekistan’s deaths of 18 children.
“We have suspended the production license of Marion Biotech company after not providing enough documents, show-cause notice was also given by the state licensing authority depending upon the documents asked during the inspection which they didn’t provide,” said Gautam Buddh Nagar Drug inspector Vaibhav Babbar.
He further said that sample results are still pending.
Union Health Minister Mansukh Mandaviya stated last month that all manufacturing activities of the Noida-based pharma company had been halted due to reports of contamination in cough syrup Dok1 Max.